UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Ventoline2mgmllosningnebulisator-SE-PLC-RA

Generated Narrative: RegulatedAuthorization Ventoline2mgmllosningnebulisator-SE-PLC-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/11088

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100000307-00011088,http://ema.europa.eu/fhir/eurdId#10330; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Nebuliser solution; indication = För symtomlindring av bronkkonstriktion vid astma och för lindring av svåra akuta och kroniska kramptillstånd i luftvägarna (KOL). Ventoline lösning för nebulisator är indicerat för vuxna, ungdomar och barn i åldern 4 till 11 år.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = salbutamol

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 1990-02-02

holder: Organization GlaxoSmithKline AB

Cases

-TypeDate[x]
*First Authorisation1990-02-02